Ryvu Therapeutics SA (RVU) — Net Asset Quality Index
Ryvu Therapeutics SA (RVU) has a Net Asset Quality Index of 24.0% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of zł224.44 Million minus total liabilities of zł170.60 Million yields net assets of zł53.83 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check RVU asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Ryvu Therapeutics SA Net Asset Quality Index Over Time (2010–2025)
This chart shows how Ryvu Therapeutics SA's Net Asset Quality Index has evolved across 16 annual periods from 2010 to 2025. As of December 2025, the index stands at 24.0%, representing net assets of zł53.83 Million against total assets of zł224.44 Million PLN. See Ryvu Therapeutics SA working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Ryvu Therapeutics SA (2010–2025)
The table below presents the year-by-year Net Asset Quality Index for Ryvu Therapeutics SA from 2010 to 2025, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Ryvu Therapeutics SA (RVU) market capitalisation.
| Year | Quality Index | Net Assets (PLN) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 24.0% | zł53.83 Million | zł224.44 Million | zł170.60 Million | ▼ -14.0 pp |
| 2024 | 38.0% | zł143.88 Million | zł378.78 Million | zł234.89 Million | ▼ -26.4 pp |
| 2023 | 64.4% | zł259.59 Million | zł403.20 Million | zł143.61 Million | ▼ -7.9 pp |
| 2022 | 72.3% | zł343.39 Million | zł474.98 Million | zł131.59 Million | ▼ -1.7 pp |
| 2021 | 74.0% | zł169.42 Million | zł228.81 Million | zł59.39 Million | ▼ -1.6 pp |
| 2020 | 75.7% | zł223.72 Million | zł295.64 Million | zł71.92 Million | ▲ +10.2 pp |
| 2019 | 65.5% | zł119.76 Million | zł182.89 Million | zł63.13 Million | ▼ -10.7 pp |
| 2018 | 76.2% | zł194.86 Million | zł255.70 Million | zł60.84 Million | ▲ +14.4 pp |
| 2017 | 61.8% | zł64.00 Million | zł103.57 Million | zł39.58 Million | ▼ -0.7 pp |
| 2016 | 62.5% | zł55.71 Million | zł89.12 Million | zł33.41 Million | ▼ -9.3 pp |
| 2015 | 71.9% | zł46.88 Million | zł65.24 Million | zł18.36 Million | ▲ +37.3 pp |
| 2014 | 34.5% | zł9.25 Million | zł26.80 Million | zł17.55 Million | ▲ +17.1 pp |
| 2013 | 17.4% | zł3.13 Million | zł17.98 Million | zł14.85 Million | ▼ -18.6 pp |
| 2012 | 36.0% | zł5.53 Million | zł15.35 Million | zł9.82 Million | ▼ -29.4 pp |
| 2011 | 65.5% | zł11.46 Million | zł17.50 Million | zł6.04 Million | ▲ +50.9 pp |
| 2010 | 14.6% | zł1.50 Million | zł10.27 Million | zł8.77 Million | — |